News & Analysis as of

Trump Administration › Department of Justice (DOJ) › Schedule I Drugs

Bradley Arant Boult Cummings LLP

DEA Judge Overseeing Rescheduling Process Retires, Further Casting Doubt on the Likelihood of Any Change in the Near Term

Bradley Arant Boult Cummings LLP on

We’ve written before that with rescheduling, with all of the excitement and pomp and circumstance that came with its announcement in the last year of the Biden administration, the whole thing was beginning to look like it may...more

Bradley Arant Boult Cummings LLP

DEA Reschedules Rescheduling, and I’m Feeling a Little Like Charlie Brown Trying to Kick the Football

Bradley Arant Boult Cummings LLP on

No, it’s not (just) a cruel play on words. Last week, the Drug Enforcement Administration announced a much-anticipated public hearing on the proposal to reschedule marijuana from early December until the first quarter of...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide